TEVA BIOPHARMACEUTICALS USA INC has a total of 23 patent applications. Its first patent ever was published in 2008. It filed its patents most often in China, Australia and Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GHAYUR TARIQ, IPROTEOS S L and SELEXYS PHARMACEUTICALS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | Australia | 3 | |
#3 | Israel | 3 | |
#4 | United States | 3 | |
#5 | Canada | 2 | |
#6 | EAPO (Eurasian Patent Organization) | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Brazil | 1 | |
#9 | New Zealand | 1 | |
#10 | Ukraine | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Roschke Viktor | 18 |
#2 | Kanakaraj Palanisamy | 18 |
#3 | Smith Rodger | 17 |
#4 | Rosen Craig | 14 |
#5 | Cooksey Bridget A | 14 |
#6 | Rosen Craig A | 2 |
#7 | Sanyal Indrajit | 1 |
#8 | Luo Xia | 1 |
#9 | Herpst Jeffrey | 1 |
#10 | Bock Jason Benjamin | 1 |
Publication | Filing date | Title |
---|---|---|
EP2411412A1 | Humanized antibodies against light and uses thereof | |
CN102395379A | New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor | |
AU2008320987A1 | Humanized antibodies against TL1A |